Vitexia-glucoside

CAS No. 38950-94-6

Vitexia-glucoside( 4'-O-Glucosylvitexin )

Catalog No. M20439 CAS No. 38950-94-6

Vitexia-glucoside is a natural product isolated from Briza stricta.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 210 In Stock
10MG 315 In Stock
25MG 565 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Vitexia-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Vitexia-glucoside is a natural product isolated from Briza stricta.
  • Description
    Vitexia-glucoside is a natural product isolated from Briza stricta.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4'-O-Glucosylvitexin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    38950-94-6
  • Formula Weight
    594.52
  • Molecular Formula
    C27H30O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (168.2 mM)
  • SMILES
    OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2cc(=O)c3c(O)cc(O)c([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c3o2)[C@H](O)[C@@H](O)[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xu* H Zhou* T Wen J et al. Isolation and Purification of Three Flavonoids from the Hawthorn Leaves by High Speed Countercurrent Chromatography Combined with Isocratic Preparative Reversed-Phase High Performance Liquid Chromatography[J]. Journal of Liquid Chromatography & Related Technologies 2009 32(15):2216-2231.
molnova catalog
related products
  • GSK-3 inhibitor 3

    GSK-3 inhibitor 3 is a selective, orally active, brain-permeable GSK-3 inhibitor that inhibits GSK-3α and GSK-3β with IC50s of 0.35 nM and 0.25 nM, respectively.

  • Olivetol Dimethyl Et...

    Olivetol Dimethyl Ether is a monoacylglycerol with analgesic activity and potential anti-inflammatory activity that inhibits fatty acid synthesis.

  • Compound C108

    Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.